510(k) · Cleared
ClearedTrue Flow Valvuloplasty Perfusion Catheter
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
C.R. Bard, Inc. · OZT Balloon Aortic Valvuloplasty
Cleared on Dec 13, 2017 as substantially equivalent to K152613 (C.R. Bard, Inc., 2016) after a 78-day review. Its family tree reaches back 4 generations to 2012. 1 later device descends from it.
- Decided
- Dec 13, 2017
- Review
- 78 days
- Class
- Class II
- Product code
- OZT
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 4 generations to K121083 (2012). 1 later device descends from it, 1 citing it directly.
- Root · 4 generations backK121083 True Dilatation Percutaneous Transluminal Valvuloplasty Catheter…Loma Vista Medical · 2012 · Recalled
- 3 generations backK133569 True Dilatation Balloon Valvuloplasty Catheter, 20MM X 4.5 CM, 22MM…Bard Peripheral Vascular, Inc. · 2013
- 2 generations backK142083 True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc. · 2015
- 1 generation backK152613 True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc. · 2016
- This deviceK172932 True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc. · 2017
- Descendant · cites it directly · 0 of its ownK241562 OutFlo Aortic Valve Dilatation Balloon CatheterDisa Medinotec · 2025
Most influential descendants
Showing 1 of 1 · See all- K241562OutFlo Aortic Valve Dilatation Balloon CatheterDisa Medinotec · 2025 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K121083 | True Dilatation Percutaneous Transluminal Valvuloplasty Catheter, 20MM X… | Loma Vista Medical | 2012 | 1 |
| −3 | K133569 | True Dilatation Balloon Valvuloplasty Catheter, 20MM X 4.5 CM, 22MM X 4.5CM… | Bard Peripheral Vascular, Inc. | 2013 | — |
| −2 | K142083 | True Flow Valvuloplasty Perfusion Catheter | C.R. Bard, Inc. | 2015 | — |
| −1 | K152613 | True Flow Valvuloplasty Perfusion Catheter | C.R. Bard, Inc. | 2016 | — |
| 0 (this device) | K172932 | True Flow Valvuloplasty Perfusion Catheter | C.R. Bard, Inc. | 2017 | — |
| +1 | K241562 | OutFlo Aortic Valve Dilatation Balloon Catheter | Disa Medinotec | 2025 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OZT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new OZT device
- #1 K253855 KardiaPSI Balloon Catheterscore 11.3 · 1 generation · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K152613 | True Flow Valvuloplasty Perfusion CatheterSummary page 4…latory Class: II Regulation Number: 21 CFR 870.1255 Predicate Device: Name of Device: True® Flow Valvuloplasty Perfusion Catheter (K152613) Common or Usual Name: Balloon Aortic Valvuloplasty Classification Name: Balloon Aortic Valvuloplasty R… | 2016 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K241562 | OutFlo Aortic Valve Dilatation Balloon Catheter | 2025 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 5 years and passes through 3 companies; a new generation was cleared every 1.3 years on median.
- 1 of the 4 ancestors has a recall of any class.
- Of its descendants, K241562 (Disa Medinotec, 2025) has gone furthest, with 0 descendants of its own.
How does its category compare?
All OZT devicesOZT Balloon Aortic Valvuloplasty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.
FDA decisions per year · OZT
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · OZT
115in 2015
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · OZT
No recall names OZT since 2007.
Adverse event reports per year · OZT
34in 2025
MAUDE reports naming product code OZT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 3 | — | 0 | 0 |
| 2013 | 3 | 80 | 0 | 29 |
| 2014 | 4 | 79 | 0 | 17 |
| 2015 | 4 | 115 | 0 | 16 |
| 2016 | 1 | — | 0 | 9 |
| 2017 | 1 | — | 0 | 38 |
| 2018 | 0 | — | 0 | 31 |
| 2019 | 0 | — | 0 | 10 |
| 2020 | 0 | — | 0 | 11 |
| 2021 | 0 | — | 0 | 18 |
| 2022 | 1 | — | 0 | 33 |
| 2023 | 1 | — | 0 | 47 |
| 2024 | 1 | — | 0 | 38 |
| 2025 | 1 | — | 0 | 34 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
The True® Flow Valvuloplasty Perfusion Catheter is indicated for balloon aortic valvuloplasty.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K172932 · printed Nov 6, 2026
Cite this page
510(k) Report. “K172932: True Flow Valvuloplasty Perfusion Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K172932
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026